| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments on deferred financing costs | - | 0 |
| Proceeds from notes payable | 0 | - |
| Net cash provided by financing activities | 5,037 | 2,589 |
| Net change in cash and cash equivalents | -1,798 | -2,035 |
| Cash and cash equivalents at beginning of period | 2,873 | - |
| Cash and cash equivalents at end of period | 1,075 | - |
Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK)